After being arrested on securities fraud charges last week, Martin Shkreli has been terminated from his other pharmaceutical company. No mention was made of either David Moradi or Marek Biestek, both of whom were also elected to the board of KaloBios when Shkreli took over the company.
Advertisement
Claudio Ranieri not thinking about Leicester’s Premier League title chances
Branislav Ivanovic , Pedro and Oscar scored the goals to lift them to 15th, albeit still only four points above the bottom three. Many Premier League observers will suggest that the Foxes will not be able to carry on this form for the rest of the season.
Shkreli resigned as the head of Turing Pharmaceuticals last week, a day after being arrested on securities fraud charges unrelated to his business practices in the pharmaceutical field.
Rummenigge: I know Guardiola’s next club – but won’t say who
Indeed, that winning mentality is part of the 44-year-old’s nature, and he is unlikely to let his standards slip over the next six months.
His Twitter account was hacked by an unknown attacker on Sunday.
Cosby sues model Beverly Johnson for defamation
Cosby have been the centerpiece of her attempted resurgence and she has played them to the hilt”, Cosby’s lawsuit states. He also wants Johnson to retract her statement, as well as remove a chapter about the alleged incident from her memoir.
Ron Tilles, chairman of the Board of Directors for Turing, has been named CEO of the privately-held biopharmaceutical company. He was released on $5 million bail.
By Friday, Shkreli, his face dark and downcast in a gray hoodie, was plastered across the front pages of The New York Times and The Wall Street Journal, announcing his arrest on suspicion of securities fraud.
Shkreli was already widely reviled because a drug company he founded raised the price of a life-saving drug from $13.50 to $750 per pill. After stating he would lower the price of Daraprim, the drug that helps keep HIV victims alive, Shkreli decided he wouldn’t after all as soon as the media attention died down. Tony Chase, a board member that joined KaloBios in November when Shkreli acquired 70% of the company, has also left the company.
In the month leading up to Shkreli’s arrest last week, KaloBios said it would buy the rights to a treatment for Chagas disease that was not approved in the US, ask the Food and Drug Administration for approval, and if successful, sell it at prices similar to hepatitis C drugs.
Shkreli bought his way into another company recently, in an attempt to repeat his previous drug price gouging act. “Willing to donate hundreds of thousands to charities before I go to prison”, and asking people to re-tweet a message for a chance to win the one-of-a-kind Wu-Tang Clan album that he notoriously paid $2 million for. The company wouldn’t answer questions Monday about who will take control and when its shares will resume trading.
Advertisement
The debts allegedly were owed to investors defrauded in two now-defunct Shkreli hedge funds that focused on health care investments: MSMB Capital and MSMB Healthcare.
